Paper762168
Different accessibilities in chromatin to histone acetylase.
Cousens LS and 2 others. J Biol Chem, 1979. Cited by 326 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Different accessibilities in chromatin to histone acetylase. Papers, record 762168. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/762168
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amidohydrolases | Major topic |
| Chromatin | Major topic |
| Histone Deacetylases | Major topic |
| Animals | |
| Butyrates | |
| Cattle | |
| Cell Line | |
| Fatty Acids | |
| Histones | |
| Kinetics | |
| Structure-Activity Relationship | |
| Thymus Gland |
Source PubMed
Cited by109
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 326 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41787017 | The gut as a central hub for multi-organ crosstalk in aging. | Cell Mol Life Sci | 2026 | https://conductscience.org/library/papers/41787017 | PubMed |
| 40869399 | Neurophysiological Basis of Short-Chain Fatty Acid Action in Pain Modulation: Therapeutic Implications. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40869399 | PubMed |
| 40671709 | Dysregulation of metabolites and high-altitude illnesses development under plateau conditions. | Front Physiol | 2025 | https://conductscience.org/library/papers/40671709 | PubMed |
| 40558532 | Epigenetic Reprogramming of Cell Identity in the Rat Primary Neuron-Glia Cultures Involves Histone Serotonylation. | Cells | 2025 | https://conductscience.org/library/papers/40558532 | PubMed |
| 40509292 | A Short-Chain Fatty Acid, Butyrate, Suppresses the Hyperexcitability of Rat Nociceptive Primary Neurons Involved in Inflammatory Hyperalgesia. | Molecules | 2025 | https://conductscience.org/library/papers/40509292 | PubMed |
| 40460326 | Modifying microbially derived short chain fatty acids to promote health. | J Physiol | 2026 | https://conductscience.org/library/papers/40460326 | PubMed |
| 40180786 | Sodium butyrate attenuates liver fibrogenesis via promoting H4K8 crotonylation. | Mol Cell Biochem | 2025 | https://conductscience.org/library/papers/40180786 | PubMed |
| 38859825 | Potential antitumor effects of short-chain fatty acids in breast cancer models. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/38859825 | PubMed |
| 38818227 | Deciphering the complex interplay of risk factors in type 2 diabetes mellitus: A comprehensive review. | Metabol Open | 2024 | https://conductscience.org/library/papers/38818227 | PubMed |
| 38304546 | Unraveling the gut health puzzle: exploring the mechanisms of butyrate and the potential of High-Amylose Maize Starch Butyrate (HAMSB) in alleviating colorectal disturbances. | Front Nutr | 2024 | https://conductscience.org/library/papers/38304546 | PubMed |
| 37560311 | Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37560311 | PubMed |
| 36831324 | Mechanisms of Blood-Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids. | Cells | 2023 | https://conductscience.org/library/papers/36831324 | PubMed |
| 36733248 | Role of Gut Microbiome in Atherosclerosis: Molecular and Therapeutic Aspects. | Curr Cardiol Rev | 2023 | https://conductscience.org/library/papers/36733248 | PubMed |
| 36301501 | Metabolic Regulation of Lysine Acetylation: Implications in Cancer. | Subcell Biochem | 2022 | https://conductscience.org/library/papers/36301501 | PubMed |
| 36173071 | Potential Therapeutic Effects of Short-Chain Fatty Acids on Chronic Pain. | Curr Neuropharmacol | 2024 | https://conductscience.org/library/papers/36173071 | PubMed |
| 35936744 | Tumor microbiome metabolism: A game changer in cancer development and therapy. | Front Oncol | 2022 | https://conductscience.org/library/papers/35936744 | PubMed |
| 35860662 | Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease. | Front Physiol | 2022 | https://conductscience.org/library/papers/35860662 | PubMed |
| 35745496 | Manipulating Microbiota to Treat Atopic Dermatitis: Functions and Therapies. | Pathogens | 2022 | https://conductscience.org/library/papers/35745496 | PubMed |
| 35409339 | Butyrate Prevents Induction of CXCL10 and Non-Canonical IRF9 Expression by Activated Human Intestinal Epithelial Cells via HDAC Inhibition. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409339 | PubMed |
| 35362379 | The Potential Role of Gut Microbiota in the Pathogenesis of Type 2 Diabetes Mellitus via Epigenetics and Inflammasome. | Endocr Metab Immune Disord Drug Targets | 2022 | https://conductscience.org/library/papers/35362379 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/762168
GET https://conductscience.org/api/papers/v1/762168/cited_by?page=2